Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03776903 · ClinicalTrials.gov registry record
Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA
A clinical trial, sponsored by InBios International.
- Completed
- Registry status
- 600
- Enrollment target
NCT03776903 is a clinical trial that has completed, run by InBios International. The registered enrollment target is 600 participants.
The verdict
NCT03776903 has completed, sponsored by InBios International.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the performance of the ZIKV Detect™ 2.0 IgM Capture ELISA using archived confirmed ZIKV positive and confirmed ZIKV negative human serum samples.
Interventions
- OTHER ZIKV Detect™ 2.0 IgM Capture ELISA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2018-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03776903
The ClinicalTrials.gov registry entry for NCT03776903 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InBios International, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ZIKV Detect™ 2.0 IgM Capture ELISA is the first listed.
NCT03776903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03776903 about?
NCT03776903 is a clinical study titled "Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA". The purpose of this study is to evaluate the performance of the ZIKV Detect™ 2.0 IgM Capture ELISA using archived confirmed ZIKV positive and confirmed ZIKV negative human serum samples.
What is the current status of trial NCT03776903?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2018-04-01. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT03776903?
The interventions under investigation include: ZIKV Detect™ 2.0 IgM Capture ELISA (OTHER).
Who is sponsoring clinical trial NCT03776903?
This trial is sponsored by InBios International, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.